Specific code 2015 ICD-9-CM Diagnosis Code 209.22
Malignant carcinoid tumor of the thymus
  • 2015
  • Billable Thru Sept 30/2015
  • Non-Billable On/After Oct 1/2015

  • ICD-9-CM 209.22 is a billable medical code that can be used to indicate a diagnosis on a reimbursement claim, however, 209.22 should only be used for claims with a date of service on or before September 30, 2015. For claims with a date of service on or after October 1, 2015, use an equivalent ICD-10-CM code (or codes).
Convert to ICD-10-CM: 209.22 converts directly to:
  • 2015/16 ICD-10-CM C7A.091 Malignant carcinoid tumor of the thymus
Approximate Synonyms
  • Cancer of the thymus, carcinoid tumor
  • Malignant carcinoid tumor of thymus
  • Malignant carcinoid tumor, thymus
  • Malignant neuroendocrine tumor of thymus
  • Malignant neuroendocrine tumor, thymus
  • Primary malignant neuroendocrine tumor of thymus
Clinical Information
  • A primary thymic neuroendocrine neoplasm, often associated with cushing's syndrome. Two morphologic subtypes are recognized: typical and atypical carcinoid tumors. Atypical carcinoid tumors have a more aggressive clinical course
  • A primary thymic neuroendocrine tumor, often associated with cushing syndrome. Two morphologic subtypes are recognized: typical and atypical carcinoid tumors. Atypical carcinoid tumors have a more aggressive clinical course
ICD-9-CM Volume 2 Index entries containing back-references to 209.22:
ICD-9-CM codes are used in medical billing and coding to describe diseases, injuries, symptoms and conditions. ICD-9-CM 209.22 is one of thousands of ICD-9-CM codes used in healthcare. Although ICD-9-CM and CPT codes are largely numeric, they differ in that CPT codes describe medical procedures and services. Can't find a code? Start at the root of ICD-9-CM, check the 2015 ICD-9-CM Index or use the search engine at the top of this page to lookup any code.